Biomerica
BMRA
35 hedge funds and large institutions have $3.43M invested in Biomerica in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 4 closing their positions.
0.31% less ownership
Funds ownership: 3.28% → 2.97% (-0.31%)
3% less funds holding
Funds holding: 36 → 35 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
43% less capital invested
Capital invested by funds: $6M → $3.43M (-$2.57M)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$22.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.94K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$357 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Potomac Capital Management
New York
|
-$287K |
| 2 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
-$81.6K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$74.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$59.5K |
| 5 |
VF
Virtu Financial
New York
|
-$15K |
BMRA Hedge Fund Activity: Q3 2023 in Review
35 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q3 2023, worth a combined $3.43M — down 43% from $6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BMRA and 3 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 5 added.
The largest buyer was Granahan Investment Management, adding an estimated $22.3K. The largest seller was Potomac Capital Management, cutting an estimated $287K.
- 35 institutional investors held Biomerica (BMRA) as of Q3 2023, down from 36 in Q2 2023.
- Funds reported $3.43M of Biomerica stock for Q3 2023, down 43% quarter-over-quarter.
- 3 funds opened new Biomerica positions in Q3 2023 and 4 closed out, a net change of -1 holder.
- The largest Biomerica buyer in Q3 2023 was Granahan Investment Management, an estimated $22.3K added.
- The largest Biomerica seller in Q3 2023 was Potomac Capital Management, an estimated $287K sold.
Based on aggregated 13F filings for Q3 2023.